Ocugen, Inc.: adjourns vote to increase common shares to Oct 26, 2026

What happened Ocugen, Inc. filed an 8-K reporting that on Oct 5, 2026 it reconvened its Special Meeting of Stockholders, which had been adjourned on Sep 21, 2026 solely with respect to Proposal 1, and then adjourned the meeting again, solely with respect to Proposal 1, to Oct 26, 2026 at 8:00 a.m., Eastern Time. Proposal 1 is an amendment to the Company’s Sixth Amended and Restated Certificate of Incorporation to increase the number of authorized shares of common stock by 250,000,000 shares.

Key details

• Reconvened and adjourned date: Oct 5, 2026; new adjourned meeting date: Oct 26, 2026 at 8:00 a.m., Eastern Time (virtual at www.virtualshareholdermeeting.com/OCGN2026SM).
• Proposal 1: increase authorized common stock by 250,000,000 shares.
• Record date for voting: Jul 27, 2026 remains the record date.
• Stockholders who previously submitted a proxy or voted and do not wish to change their vote on Proposal 1 do not need to take any action.

Why it may matter The filing reports Item 5.07: submission of matters to a vote of security holders, covering the reconvening and adjournment of a special meeting for stockholder consideration of an amendment to increase authorized common shares. The filing does not show why the company acted.